Biohit Oyj Financial calendar, December 09, 2020 at 4:30 pm local time (EET) · Biohit Oyj will release its financial statements for 2020 on Wednesday 17[th] of February 2021 at 9:30 am. · The Annual Report, which contains the Financial Statements for 2020 and the Report of the Board of Directors, will be published approximately during week 12. · Biohit Oyj’s Annual General Meeting has been planned for Wednesday 21[th] of April 2021 at 5:00 pm. The Board of Directors will call the General Meeting at a later date. · Half year financial report for period January-June (H1) 2021 will be published on Wednesday 11[th] of August 2021 at 9:30 am. The published economic reports and other stock exchange releases are available on Biohit's website at www.biohithealthcare.com/investors. The website also contains an online form for ordering electronic copies, which will be e-mailed to you, available at http://www.biohithealthcare.com/investors/stock-exchange -releases/order-releases-to-your-email. Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com